Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

Paolo Catarsi, Francesca Cordero, Giulio Ferrero, Marco Beccuti, Valentina Poletto, Elisa Bonetti, PhD, Laura Villani, Margherita Massa, Gabriela Fois, Rita Campanelli, Umberto Magrini, Vittorio Rosti, Giovanni Barosi

Blood (2016) 128 (22): 4279.

https://doi.org/10.1182/blood.V128.22.4279.4279

Published: 2016

Journal Articles

High Levels of High Sensitivity-C Reactive Protein (hs-CRP) Are Associated with Older Age, Chromosomal Abnormalities and JAK2V617F Mutation with High Allele Burden in Primary Myelofibrosis (PMF)

Giovanni Barosi, Margherita Massa, Gabriela Fois, Rita Campanelli, Elisa Bonetti, PhD, Valentina Poletto, Laura Villani, Paolo Catarsi, Vittorio Rosti

Blood (2016) 128 (22): 1956.

https://doi.org/10.1182/blood.V128.22.1956.1956

Published: 2016

Journal Articles

Reduced frequency of circulating CD4 + CD25 bright CD127 low FOXP3 + regulatory T cells in primary myelofibrosis

Margherita Massa, Rita Campanelli, Gabriela Fois, Laura Villani, Elisa Bonetti, Paolo Catarsi, Valentina Poletto, Gianluca Viarengo, Mara De Amici, Vittorio Rosti, Robert Peter Gale, Giovanni Barosi

Blood (2016) 128 (12): 1660–1662.

https://doi.org/10.1182/blood-2016-03-704577

Published: 2016

Includes: Supplemental data

Journal Articles

Reduced Frequency of CD4+CD25++CD127low/-FOXP3+ Regulatory T Cells in Patients with Primary Myelofibrosis

Margherita Massa, PhD, Rita Campanelli, BS, Gabriela Fois, BS, Laura Villani, BS,, Elisa Bonetti, PhD, Paolo Catarsi, BS, Valentina Poletto, PhD, Gianluca Viarengo, MD, Vittorio Rosti, MD, Giovanni Barosi, MD

Blood (2015) 126 (23): 2809.

https://doi.org/10.1182/blood.V126.23.2809.2809

Published: 2015

Journal Articles

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

Rita Campanelli, BS, Gabriela Fois, BS, Carlotta Abbà, BS, Mara De Amici, BS, Laura Villani, BS,, Elisa Bonetti, PhD, Paolo Catarsi, BS, Valentina Poletto, PhD, Giovanni Barosi, MD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2015) 126 (23): 1639.

https://doi.org/10.1182/blood.V126.23.1639.1639

Published: 2015

Journal Articles

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

Laura Villani, BS,, Rita Campanelli, BS, Gabriella Gaudioso, BS, Valentina Poletto, PhD, Elisa Bonetti, PhD, Paolo Catarsi, BS, Gabriela Fois, BS, Benedetta G Erba, PhD, Margherita Massa, PhD, Umberto Magrini, MD, Giovanni Barosi, MD, Umberto Gianelli, MD, Vittorio Rosti, MD

Blood (2015) 126 (23): 2833.

https://doi.org/10.1182/blood.V126.23.2833.2833

Published: 2015

Journal Articles

What Is the True Response Rate to Ruxolitinib in Persons with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) Needing Therapy for Splenomegaly ?

Giovanni Barosi, MD, Valentina Poletto, Biol Sci, Elisa Bonetti, BS, Laura Villani, Biol Sci, Paolo Catarsi, PhD, Gianluca Viarengo, MD, Rita Campanelli, Biol. Sci, Margherita Massa, PhD, Vittorio Rosti, MD

Blood (2014) 124 (21): 3191.

https://doi.org/10.1182/blood.V124.21.3191.3191

Published: 2014

Journal Articles

Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis

Blood (2014) 124 (21): 3227.

https://doi.org/10.1182/blood.V124.21.3227.3227

Published: 2014

Journal Articles

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Giovanni Barosi, MD, Rita Campanelli, Biol. Sci, Gabriela Fois, Biol. Sci, Valentina Poletto, Biol. Sci, Laura Villani, Biol. Sci, Elisa Bonetti, BS, Paolo Catarsi, PhD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2013) 122 (21): 4057.

https://doi.org/10.1182/blood.V122.21.4057.4057

Published: 2013

Journal Articles

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Giovanni Barosi, MD, Elisa Bonetti, BS, Paolo Catarsi, PhD, Margherita Massa, PhD, Rita Campanelli, Biol.Sci, Valentina Poletto, Biol.Sci, Gianluca Viarengo, MD, Laura Villani, Biol.Sci, Gabriela Fois, Biol.Sci, Flavia Biamonte, BiSci, PhD, Giada Rotunno, BiSci, Paola Guglielmelli, PhD MD, Umberto Magrini, MD, Alessandro M Vannucchi, MD, Vittorio Rosti, MD

Blood (2013) 122 (21): 4058.

https://doi.org/10.1182/blood.V122.21.4058.4058

Published: 2013

Journal Articles

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

Blood (2013) 121 (2): 360–368.

https://doi.org/10.1182/blood-2012-01-404889

Published: 2013

Includes: Supplemental data

Journal Articles

JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis.

Giovanni Barosi, MD, Valentina Poletto, Biol Sci, Margherita Massa, Ph D, Rita Campanelli, Biol. Sci, Laura Villani, Biol Sci, Elisa Bonetti, Biol Sci, Gianluca Viarengo, MD, Paolo Catarsi, PhD, Catherine Klersy, MD, Vittorio Rosti, MD

Blood (2012) 120 (21): 2829.

https://doi.org/10.1182/blood.V120.21.2829.2829

Published: 2012

Journal Articles

A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation

Valentina Poletto, Vittorio Rosti, Laura Villani, Paolo Catarsi, Adriana Carolei, Rita Campanelli, Margherita Massa, Myriam Martinetti, Gianluca Viarengo, Alberto Malovini, Anna Rita Migliaccio, Giovanni Barosi

Blood (2012) 120 (15): 3112–3117.

https://doi.org/10.1182/blood-2012-05-433466

Published: 2012

Journal Articles

JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF),

Paolo Catarsi, PhD, Vittorio Rosti, MD, Vittorio Abbonante, BS, Alessandra Balduini, MD, Gaetano Bergamaschi, MD, Elisa Bonetti, Biol Sci, Valentina Poletto, Biol Sci, Laura Villani, Biol Sci, Giovanni Barosi, MD

Blood (2011) 118 (21): 3844.

https://doi.org/10.1182/blood.V118.21.3844.3844

Published: 2011

Journal Articles

Prefibrotic Myelofibrosis (PreMF) Belongs to a Continuum of Epidemiological, Clinical and Histological Characteristics Featuring Primary Myelofibrosis (PMF)

Giovanni Barosi, MD, Vittorio Rosti, MD, Rita Campanelli, Biol. Sci, Paolo Catarsi, PhD, Antonina M. Isgrò, Lab Tech, Letizia Lupo, MD, Margherita Massa, Ph D, Valentina Poletto, Biol Sci, Gianluca Viarengo, MD, Laura Villani, Biol Sci, Umberto Magrini, MD

Blood (2011) 118 (21): 1743.

https://doi.org/10.1182/blood.V118.21.1743.1743

Published: 2011

NARROW

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

High Levels of High Sensitivity-C Reactive Protein (hs-CRP) Are Associated with Older Age, Chromosomal Abnormalities and JAK2V617F Mutation with High Allele Burden in Primary Myelofibrosis (PMF)

Reduced frequency of circulating CD4 + CD25 bright CD127 low FOXP3 + regulatory T cells in primary myelofibrosis

Reduced Frequency of CD4+CD25++CD127low/-FOXP3+ Regulatory T Cells in Patients with Primary Myelofibrosis

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

What Is the True Response Rate to Ruxolitinib in Persons with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) Needing Therapy for Splenomegaly ?

Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis.

A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation

JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF),

Prefibrotic Myelofibrosis (PreMF) Belongs to a Continuum of Epidemiological, Clinical and Histological Characteristics Featuring Primary Myelofibrosis (PMF)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only